Digital Therapeutics

Holmusk & Merck partner to improve treatment outcomes for prediabetes & diabetes patients in APAC | MobiHealthNews | 11/11/2020

… business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes. The partnership involves Holmusk’s GlycoLeap, a mobile digital therapeutics platform that utilizes a highly data-driven approach to deliver personalized dietary feedback, interactive educational lessons, and 1-1 guidance with a qualified health coach. The goal is to help patients achieve weight loss and …

Apple Watch prescription sleep app from NightWare earns FDA approval | Business Insider | 11/11/2020

… of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. For a limited time, you can try the Briefing for a full week for just $1! The FDA gave digital therapeutics (DTx) firm NightWare clearance for its Apple Watch app designed to improve sleep quality and help individuals suffering from PTSD. Apple Watch sleep app from NightWare gains FDA nod. NightWare's platform uses …

Follow Digital Therapeutics:    

Cohero Health’s digital respiratory assets get scooped up by AptarPharma | MobiHealthNews | 11/5/2020

… venture-backed respiratory-focused startup was founded in 2013 and has raised over $15 million from big names, including fellow tech companies Samsung and Omron. Since its inception, the company has focused on the digital therapeutics space. In 2015, it landed its first FDA clearance for its smartphone-connected spirometer, which could monitor lung function and send the data back to an app. WHY IT MATTERS As part of the …

Pear’s reSET-O for opioid use disorder saves payers $2,150 per patient, real-world claims review finds | MobiHealthNews | 11/5/2020

The study, backed by the digital therapeutics company, measured the change in clinical encounter frequency among opioid use disorder patients who were also prescribed buprenorphine. 01:55 pm Share A recently published review of real-world claims data suggests that opioid use disorder patients prescribed Pear Therapeutics’ reSET-O digital therapeutic, alongside pharmacotherapy, had fewer clinical encounters and subsequently decreased medical costs over a six-month period. The study was funded …

Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health | HIT Consultant | 11/5/2020

… Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all operating assets and the proprietary portfolio of Cohero Health, Inc. (‚ÄúCohero Health‚Äù), a digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD). Financial details of the acquisition were not disclosed. Start breathing smarter Founded in 2013, New York-based Cohero Health develops innovative …

Orexo Interim Report Q3 2020 - GuruFocus.com | 11/4/2020

… 816.8 -27% CEO Comments Keeping focus and maximizing business opportunities in a challenging environment It has been an eventful third quarter for Orexo, with good progress made in establishing our new business area in digital therapeutics . The quarter also brought some new challenges, primarily from new legal processes and impact from Covid-19. I am pleased that we have shown agility and determination in responding to these challenges, which I …

Orexo Interim Report Q3 2020 | BioSpace | 11/4/2020

… 12.9 -27% CEO Comments Keeping focus and maximizing business opportunities in a challenging environment It has been an eventful third quarter for Orexo, with good progress made in establishing our new business area in digital therapeutics . The quarter also brought some new challenges, primarily from new legal processes and impact from Covid-19. I am pleased that we have shown agility and determination in responding to these challenges, which I …

Digital Therapeutics and Wellness Market Forecast, Size, Growth Trends, Drivers, Opportunities and Key Players – Ginger, Noom, Canary Health, Blue Mesa Health, My mHealth, AppliedVR - Aerospace Journal | 11/3/2020

Digital Therapeutics and Wellness Market Forecast, Size, Growth Trends, Drivers, Opportunities and Key Players – Ginger, Noom, Canary Health, Blue Mesa Health, My mHealth, AppliedVR Aerospace Journal from “health trends” - Google News https://ift.tt/2Jw4a3a via IFTTT …

Europe Digital Therapeutics Market Size study, by Type, Application and Regional Forecasts 2020-2030 - Biotechnology News Today - EIN Presswire | 11/3/2020

Europe Digital Therapeutics Market Size study, by Type, Application and Regional Forecasts 2020-2030 WiseGuyReports.com adds ‚ÄúEurope Digital Therapeutics Market Research Report 2020 Analysis and Forecast 2030‚Äù reports to its database. PUNE, MAHARASTRA, INDIA, Digital Therapeutics Market: Executive Summary Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices …

Human API’s $20M+ Series C, Curve Health’s $6M seed round and more digital health fundings | MobiHealthNews | 11/3/2020

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum. 12:29 pm Share Human API, maker of a consumer-facing health data sharing platform, announced last week the close of “over $20 million” in Series C funding. The raise saw backers Samsung Ventures, CNO Financial Group, Allianz Life Ventures and Moneta VC joining returning investors BlueRun Ventures, SCOR Life and Health …

Therapeutic game developer SidekickHealth raises $20M in series A round | FierceBiotech | 11/2/2020

With plans to use video game elements to build care programs for multiple chronic diseases and conditions, SidekickHealth has raised $20 million in venture capital to support its projects. The Swedish digital therapeutics developer‚Äôs series A investment round was led by Wellington Partners and Asabys Partners, through its fund SAHII, with additional participation by Sidekick‚Äôs previous investors Novator and Frumtak Ventures. Sidekick combines artificial intelligence and behavioral economics …

Pear Therapeutics Wins Prix Galien USA Award for Somryst‚Ñ¢ as Best Digital Health Product | Business Wire | 10/30/2020

… recognition would not have been possible without the many contributions of the people who work at Pear. We are proud to provide patients with Somryst and continue forward in our efforts to make prescription digital therapeutics standard of care across a range of diseases.‚Äù Somryst, intended for use in the treatment of patients 22 years of age and older with chronic insomnia, treats patients with chronic insomnia by improving …

Redox Integrates Voluntis’ Digital Therapeutics Within EHR | HIT Consultant | 10/30/2020

Leave a Comment What You Should Know: ‚Äì Voluntis forms a strategic partnership with Redox to integrate Voluntis‚Äô digital therapeutics within existing clinical workflows and EHRs. ‚Äì Integration of Voluntis‚Äô Theraxium platform with the Redox Engine used by more than 900 healthcare organizations using 55 EHRs across the country. ‚Äì The first area of this application will be in oncology, with future extensions in other therapeutic areas. As …

Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys | 10/28/2020

… The company collaborates with global pharmaceutical companies, payers and providers Existing investors Novator and Frumtak Ventures also participated Funding to advance European growth and expand US operations Barcelona/Munich/Reykjavik, Oct. 28, 2020 – Nordic digital therapeutics company Sidekick Health has completed a $20 million oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its fund SAHII , with participation by existing investors Novator and Frumtak Ventures. Sidekick …

Digital therapeutics and wellness app users to reach 1.4 billion by 2025 | MobiHealthNews | 10/28/2020

New study finds that as the pandemic accelerates regulatory acceptance, the market value is expected to grow by 865% over the next five years. 05:18 am Share A study from UK-based analyst house, Juniper Research has found that the number of people using digital therapeutics and wellness apps will grow from 627 million in 2020 to more than 1.4 billion in 2025. This follows regulators responding to COVID-19 …

Nordic digital therapeutics firm Sidekick Health scores $20 million in Series A funding | MobiHealthNews | 10/28/2020

… seek remote solutions. EU-based startup, Raccoon.World , recently raised $1.07 million (€900k) in seed funding, to support its gamified platform for patients recovering from injuries and neurological diseases. There is also growing opportunity for digital therapeutics firms to partner with big pharma , such as Sidekick’s collaborations with Pfizer and Bayer . Last month, Swedish pharma company Orexo launched two digital therapeutics solutions for depression and alcohol use disorders. ON THE RECORD …

Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys | 10/28/2020

Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys [October 28, 2020] Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys BARCELONA, Spain , MUNICH , and REYKJAVIK, Iceland , Oct. 28, 2020 /PRNewswire/ – Nordic digital therapeutics company Sidekick Health has completed a $20 million oversubscribed Series A financing round led by Wellington Partners and Asabys Partners, through its …

[KH Biz Forum] Future of health care amid COVID-19 - The Korea Herald | 10/27/2020

… Seoul. The forum, held under the tagline of “Contact less, connect more,” had speakers deliver talks on business outlook in the post-COVID-19 era. Choi’s speech outlined digital health care trends surrounding telemedicine, digital therapeutics and medical artificial intelligence – and where Korea stood in the global playing field.While Korea is the only country in the world that legally bans telemedicine, Choi stressed, “I would never say telemedicine regulations should …

Remote electric neuromodulation device approval extended to treatment of chronic migraine | 10/27/2020

The FDA has expanded the approval for Nerivio, a wearable remote electrical neuromodulation device controlled by a smartphone app, to treat chronic migraine in adults aged 18 years and older. Nerivio, created by the digital therapeutics company Theranica, previously was approved by the FDA for treatment of episodic migraine. Source: Grosberg B, et al. Abstract 9. Presented at: PAINWeek: Sept. 11-13, 2020. (Virtual). “The updated Nerivio indication is an important …

Sidekick Health scores $20M for its gamified digital care platform | 10/27/2020

Comments Nordic digital therapeutics company, Sidekick Health , has closed a $20 million Series A led by pan-European VC Wellington Partners and healthcare focused VC Asabys Partners. Existing investors, Novator and Frumtak Ventures, also participated in the oversubscribed round. The 2014-founded startup has built a gamified digital care platform that targets chronic and lifestyle disease management via digital nudges from a helmet-wearing cartoon helper — pushing patients toward relevant …

Nerivio® Receives Clearance of Expanded Indication to Cover Chronic Migraine Patients | BioSpace | 10/26/2020

MONTCLAIR, N.J. and NETANYA, Israel , Oct. 26, 2020 /PRNewswire/ – Theranica , a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that its Nerivio ® medical device has received Food and Drug Administration (FDA) clearance for an expanded indication encompassing acute treatment of chronic migraine in people 18 years and older. Nerivio now has clearance for use in acute treatment of migraine with or without aura …

Nerivio® Receives Clearance of Expanded Indication to Cover Chronic Migraine Patients | PR Newswire | 10/26/2020

MONTCLAIR, N.J. and NETANYA, Israel , Oct. 26, Theranica , a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that its Nerivio ® medical device has received (FDA) clearance for an expanded indication encompassing acute treatment of chronic migraine in people 18 years and older. Nerivio now has clearance for use in acute treatment of migraine with or without aura in patients 18 years of age …

Nerivio® Receives Clearance of Expanded Indication to Cover Chronic Migraine Patients | 10/26/2020

… of Expanded Indication to Cover Chronic Migraine Patients [October 26, 2020] Nerivio® Receives Clearance of Expanded Indication to Cover Chronic Migraine Patients MONTCLAIR, N.J. and NETANYA, Israel , Oct. 26, 2020 /PRNewswire/ – Theranica , a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that its Nerivio ® medical device has received Food and Drug Administration (FDA) clearance for an expanded indication encompassing acute treatment of chronic …

Nerivio receives clearance of expanded indication to cover chronic migraine patients | 10/26/2020

Print Theranica , a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, has announced that its Nerivio medical device has received FDA clearance for an expanded indication encompassing acute treatment of chronic migraine in people 18 years and older. × Expand Nerivio receives clearance of expanded indication to cover chronic migraine patients Nerivio now has clearance for use in acute treatment of migraine with or without aura …

5 ways the election will change digital health, according to CEOs, VCs - Business Insider | 10/26/2020

The 2020 presidential election could determine the future of digital health, healthcare investors and CEOs told Business Insider. The pandemic contributed to the quick adoption of digital health services like telehealth and digital therapeutics , but it's not clear how permanent their success can be without lasting policy. In addition to the Trump and Biden campaigns' diverging positions on the future of the Affordable Care Act, industry insiders …

Digital Therapies

Orexo Interim Report Q3 2020 | BioSpace | 11/4/2020

… EBIT of SEK 72.4 m (90.9) DTx segment EBIT of SEK -62.5 m (-), including US launch of the scientifically proven digital therapies deprexis¬Æ and vorvida¬Æ Cash flow from operating activities of SEK -12.9 … good progress made in establishing our new business area in digital therapeutics. The quarter also brought some new challenges, primarily from new legal processes and impact from Covid-19. I am pleased that we have …

Digital Health

Human API’s $20M+ Series C, Curve Health’s $6M seed round and more digital health fundings | MobiHealthNews | 11/3/2020

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum. 12:29 pm Share Human API, maker of a consumer-facing health data sharing platform, announced last … they can then share with employers, financial services or other digital health startups. The company said that these funds will help continue to grow its business among insurance, pharma, and digital health clients, and help …

Health Management

Human API’s $20M+ Series C, Curve Health’s $6M seed round and more digital health fundings | MobiHealthNews | 11/3/2020

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum. 12:29 pm Share Human API, maker of a consumer-facing health data sharing platform, announced last … these listed by the startup include automated patient monitoring, population health management, streamlined clinical trial recruitment and chronic disease management. “With this new capital we‚Äôre evolving Human API into a digital transformation platform unifying …

Smoking Cessation

Europe Digital Therapeutics Market Size study, by Type, Application and Regional Forecasts 2020-2030 - Biotechnology News Today - EIN Presswire | 11/3/2020

Europe Digital Therapeutics Market Size study, by Type, Application and Regional Forecasts 2020-2030 WiseGuyReports.com adds ‚ÄúEurope Digital Therapeutics Market Research Report 2020 Analysis and Forecast 2030‚Äù reports to its database. PUNE, MAHARASTRA, INDIA, Digital Therapeutics Market: Executive Summary Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices …

Chronic Disease Management

Human API’s $20M+ Series C, Curve Health’s $6M seed round and more digital health fundings | MobiHealthNews | 11/3/2020

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum. 12:29 pm Share Human API, maker of a consumer-facing health data sharing platform, announced last … patient monitoring, population health management, streamlined clinical trial recruitment and chronic disease management. “With this new capital we‚Äôre evolving Human API into a digital transformation platform unifying more data from more sources,‚Äù Andrei …

Population Health

Human API’s $20M+ Series C, Curve Health’s $6M seed round and more digital health fundings | MobiHealthNews | 11/3/2020

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum. 12:29 pm Share Human API, maker of a consumer-facing health data sharing platform, announced last … of these listed by the startup include automated patient monitoring, population health management, streamlined clinical trial recruitment and chronic disease management. “With this new capital we‚Äôre evolving Human API into a digital transformation platform …

Coronavirus

5 ways the election will change digital health, according to CEOs, VCs - Business Insider | 10/26/2020

… investors and CEOs told Business Insider. The pandemic contributed to the quick adoption of digital health services like telehealth and digital therapeutics, but it's not clear how permanent their success can be without … the Affordable Care Act and its failure to control the coronavirus pandemic, which has killed more than 230,000 Americans. “I think the ACA is on the ballot, healthcare is on the ballot, and science is …

Food and Drug Administration

FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment - - Earn 8 Magazine | HIT Consultant | 10/22/2020

Food and Drug Administration (FDA) for treating treatment-resistant fibromyalgia and chronic intractable lower back pain. EaseVRx is now one of the first virtual reality (VR) digital therapeutics to get breakthrough designation to treat conditions related to chronic pain. What is the FDA Breakthrough Device Program? The FDA Breakthrough Device Program helps patients receive more timely access to breakthrough technologies that could provide more effective treatment or diagnosis for life …

Mental Health

Ehave Expands Its Psychedelic Mental Health Platform with Medchart, a Leader in Medical Record Software, as a Plugin to the Ehave Dashboard | Globe Newswire | 10/20/2020

digital therapeutics delivering evidence-based therapeutic interventions to healthcare patients, announced today it has added Medchart, the only comprehensive solution for medical record exchange, as the first plugin to its Ehave Dashboard. This will not only allow patients to take more control over their psychedelic medical records, it will allow patients to access innovative treatments to mental health by providing clinicians and pharmaceutical companies with data that will make the …

Medication Adherence

Get in the Game: Why Biopharma Should Embrace Digital Therapeutics – PM360 | 10/19/2020

… decade, a growing number of companies have sought to answer that question by developing a new class of treatments called digital therapeutics (DTx). DTx are software or software-based solutions intended to treat or manage … and how patient behaviors such as diet, exercise, sleep, smoking, medication adherence, and others drive severity and progression for many chronic diseases, especially cardiometabolic and respiratory conditions…and how the episodic and reactive approach to …

Behavioral Health

Get in the Game: Why Biopharma Should Embrace Digital Therapeutics – PM360 | 10/19/2020

… decade, a growing number of companies have sought to answer that question by developing a new class of treatments called digital therapeutics (DTx). DTx are software or software-based solutions intended to treat or manage … that patient behavior and thought patterns play in mental and behavioral health conditions such as depression and substance use disorder…and how neurological function is at the heart of stroke recovery and ADHD…and how …

Medicare

Opinion: Medicare should break an old rule to let breakthrough digital therapeutics save lives | STAT | 10/19/2020

First Opinion Medicare should break an old rule to let breakthrough digital therapeutics save lives By Andrey Ostrovsky October 19, 2020 Reprints Adobe T he Centers for Medicare and Medicaid Services (CMS) recently issued a draft rule that could dramatically improve access to evidence-based treatments that can be delivered virtually. But it won’t unless CMS makes another seemingly simple change regarding benefit categories. Covid-19 has killed more than …

Medicaid

Opinion: Medicare should break an old rule to let breakthrough digital therapeutics save lives | STAT | 10/19/2020

First Opinion Medicare should break an old rule to let breakthrough digital therapeutics save lives By Andrey Ostrovsky October 19, 2020 Reprints Adobe T he Centers for Medicare and Medicaid Services (CMS) recently issued a draft rule that could dramatically improve access to evidence-based treatments that can be delivered virtually. But it won’t unless CMS makes another seemingly simple change regarding benefit categories. Covid-19 has killed more than …

COVID-19

Opinion: Medicare should break an old rule to let breakthrough digital therapeutics save lives | STAT | 10/19/2020

First Opinion Medicare should break an old rule to let breakthrough digital therapeutics save lives By Andrey Ostrovsky October 19, 2020 Reprints Adobe T he Centers for Medicare and Medicaid Services (CMS) recently issued a draft rule that could dramatically improve access to evidence-based treatments that can be delivered virtually. But it won’t unless CMS makes another seemingly simple change regarding benefit categories. Covid-19 has killed more than …

Medication Management

Consumers Cite Trump as Leading Driver of COVID-19 Vaccine Skepticism | HIT Consultant | 10/16/2020

digital therapeutics platform that supports users with advanced medication management. The survey reveals sixty-five percent of patients say they will wait to receive the forthcoming COVID-19 vaccine even if it becomes available before the end of 2020. The majority of survey participants cited uncertainty in its overall effectiveness and potential side-effects from the vaccine as top reasons for the delay. Report Background The survey, conducted from Sept …

Patient Empowerment

Orexo and Lyfebulb Announce the Winner of the 2020 Innovation Challenge in Substance Use Disorders | PR Newswire | 10/16/2020

… UPPSALA, Sweden and NEW YORK Orexo, a Swedish pharmaceutical company focused on improved pharmaceuticals and digital therapies, and Lyfebulb, a patient empowerment platform, announced that Rohan Dixit of Lief Therapeutics was chosen as the winner … on innovation within this space.” said Mikaela Odlander, Director of Digital Therapeutics at Orexo. “We applaud and thank the finalist companies for their engagement and hard work throughout the process and extend our most sincere …

Telehealth

Havas Health & You Launches Global Customer Experience Network, Havas Health CX | PR Newswire | 10/15/2020

digital therapeutics and the process and ways of operating within the broader health industry. 57% of providers view telehealth more favorably than they did before the pandemic, while 64% say they are more comfortable using digital technologies as we move into the future. The growing reliance and popularity of telehealth suggests that as much as $250billion of US care spending could draw from digital and virtual services post-pandemic. As …

Clinical Research

The global digital therapeutics market is projected to be worth over USD 8.9 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis | PR Newswire | 10/14/2020

LONDON Roots Analysis has announced the addition of “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and … registered since 2004 Around 80,000 patients have been enrolled in clinical research initiatives aimed at validating the efficacy of digital therapeutics, and generate real world evidence concerning their efficacy and safety. Close to 50% of …

Digital Health Market

The global digital therapeutics market is projected to be worth over USD 8.9 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis | PR Newswire | 10/14/2020

LONDON Roots Analysis has announced the addition of “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings. According to experts, digital therapeutic solutions are primarily based on behavior modification and are designed to address a variety …

Patient Monitoring

Healthcare systems need to keep innovating | Healthcare IT News | 10/8/2020

COVID-19 has accelerated the adoption of telehealth, but digital therapeutics, diagnostics and remote patient monitoring are predicted to play a more significant role moving forward, says Liz Ashall-Payne, founder and CEO of ORCHA. Subscribe today to receive our FREE monthly e-newsletter Sign Up Laura Lovett Laura Lovett is an associate editor at MobiHealthNews where she covers the intersection of healthcare and technology. She is also a contributing …

Clinical Data

Invitation – Orexo Digital Therapeutics business update October 1 | 9/25/2020

Invitation – Orexo Digital Therapeutics business update October 1 Fri, Sep 25, 2020 14:00 CET Uppsala, Sweden – September 25, 2020 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today invites investors, analysts, and media to attend a teleconference on Thursday October 1, at 3 pm CET. During the event, Orexo will provide an update on the company’s Digital Therapeutics business, and discuss clinical data demonstrating efficacy for both deprexis® and vorvida®, Orexo’s …

Pain Management

Fern Health Expands Clinical Expertise on Senior Leadership Team | PR Newswire | 9/22/2020

… digital therapeutics. Dr. Lakhan’s hire supports Fern Health’s commitment to building products and teams rooted in deep clinical expertise. “Having built and operated multidisciplinary pain services across the nation, I recognize the fractures in our traditional systems of healthcare, and the value of Fern Health’s clinically-vigorous approach,” says Dr. Lakhan. “I’m looking forward to bringing together patients, clinicians, scientists, and artificial intelligence to effectively shift the focus of pain …

Remote Monitoring

Biorasi Commended by Frost & Sullivan for its Full-service Offering to Drive Rare Disease Patient Recruitment for CROs | PR Newswire | 9/22/2020

… experts and technology to improve trial performance, especially in the DTx area. Combined with drug therapies, Biorasi aids in advancing remote monitoring, adherence, telemedicine, and disease-specific digital tools as an alternative to medication, especially … a leader in neurology, nephrology, dermatology, oncology, and the emerging digital therapeutics market. To learn more, contact Biorasi at [email protected] / (786) 388-0700. SOURCE Frost & Sullivan Related Links www.frost.com …

Cognitive Behavioral Therapy

Huami Amazfit Band 5 is a multi-feature fitness watch for only $45 | Engadget | 9/21/2020

… Use Disorder and Opioid Use Disorder PreferredOne teams with Pear to provide its members with covered access to two prescription digital therapeutics (PDTs) for the treatment of substance use disorder (SUD) and opioid use disorder … are adjunctive to outpatient counselling, provide patients with algorithm-driven cognitive behavioral therapy, fluency training, and contingency management, while clinicians receive access to clinical dashboards to inform in-office and tele visits. reSET is used …

Virtual Care

On the agenda for INVEST Digital Health virtual Day 1: Hospital innovation and startups for chronic conditions, value-based care - MedCity News | 9/21/2020

… Principal, Flare Capital Matthew Warrens , Managing Director, Innovation, UnityPoint Health Ventures Here are the startups: Cerestil Health has expertise in virtual care for seniors with cognitive impairment (e.g., dementia, stroke, Parkinson’s disease). Its digital health … CEO: Anuj Patel Headquarters: Cambridge, MA Limbix is building prescription digital therapeutics to treat adolescent mental health disorders. Its first product, Limbix Spark, is an app designed to treat adolescent depression, a leading cause of …

Apple Health

Apple Watch prescription sleep app from NightWare earns FDA approval | Business Insider | 11/11/2020

Apple Watch to manage PTSD. And agencies like the CMS will start covering digital therapies for their enrollees, giving developers access to large, untapped user bases. publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. For a limited time, you can try the Briefing for a full week for just $1! The FDA gave digital therapeutics (DTx) firm NightWare clearance for its …

Merck

Holmusk & Merck partner to improve treatment outcomes for prediabetes & diabetes patients in APAC | MobiHealthNews | 11/11/2020

Digital Therapeutics Holmusk & Merck partner to improve treatment outcomes for prediabetes & diabetes patients in APAC The partnership will leverage on Holmusk‚Äôs GlycoLeap platform to help patients achieve weight loss and improved blood glucose control. 02:57 am Share Singapore-based data science and healthcare technology company Holmusk announced a collaboration with the Healthcare business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia …

Livongo Health

Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health | 10/23/2020

RSS Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health The global report on Digital Therapeutics and Wellness market presents, through a comprehensive analysis, the newly published research study that provides key industry insights and a competitive advantage for multiple stakeholders. New York, NY – ( SBWIRE ) – 10/23/2020 – Digital Therapeutics and Wellness report shows existing business research, future as well as emerging …

Ehave

Ehave Expands Its Psychedelic Mental Health Platform with Medchart, a Leader in Medical Record Software, as a Plugin to the Ehave Dashboard | Globe Newswire | 10/20/2020

Ehave partners with world-renowned tech platform, Medchart. The Medchart plugin will allow medical professionals using the Ehave Dashboard to easily transfer medical records, while allowing patients to own their own data and do what they want with it. October 20, 2020 08:45 ET Source: Ehave MIAMI, Oct. 20, 2020 (GLOBE NEWSWIRE) – Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to …

Optum

UnitedHealth Group Inc. (UNH) Q3 2020 Earnings Call Transcript | 10/14/2020

… Officer John Rex — Office of the Chief Executive, Executive Vice President and Chief Financial Officer Wyatt Decker — Chief Executive Officer, OptumHealth Dirk McMahon — Office of the Chief Executive, Chief Executive Officer, UnitedHealthcare Tim Noel — Chief … people and producing better health outcomes. You can expect more digital therapeutics from us in the coming months and years. Our growing capacities are especially apparent within our OptumCare platform, where 53,000 physicians across 1,500 …

DarioHealth

$DRIO Platform Selected for Integration in Vitality’s Gateway Flex | 10/14/2020

DRIO Platform Selected for Integration in Vitality’s Gateway Flex DarioHealth (NASDAQ: DRIO) , a pioneer in the global digital-therapeutics market, today announced that Vitality Group has chosen the company’s digital therapeutics solutions for inclusion in Vitality’s new Gateway Flex offering. According to the update, Gateway Flex enables employers to personalize the health-care experience to meet the diverse and rapidly changing needs of their employees and allows employers to pay …

UnitedHealth

UnitedHealth Group CEO Wichmann teases development of new digital therapeutics | FierceHealthcare | 10/14/2020

Earlier this year, UnitedHealth Group unveiled a digital therapy platform for patients with diabetes called Level2. CEO David Wichmann said the company sees more opportunity to continue developing such therapies. “Our growing therapeutics capacities are … who’ve enrolled in it thus far. “You can expect more digital therapeutics from us in the coming months and years,” he added. Wichmann also touted UnitedHealth’s efforts to scale up its telehealth offerings amid COVID …

CVS Health

PBM ‘Digital Formularies’ Promote Healthier Habits with Vetted Apps | 10/9/2020

digital therapeutics that aid in the management of eight of the most common chronic conditions: diabetes, prediabetes, hypertension, asthma, pulmonary disease, depression, anxiety and insomnia. CVS Health’s Point Solutions Management helps employers to simplify contracting, secure the lowest price and monitor ongoing performance of 10 health apps, including digital programs to reduce stress, control high blood pressure, provide access to virtual physical therapy, lose weight and improve sleep habits, for …

CVS

PBM ‘Digital Formularies’ Promote Healthier Habits with Vetted Apps | 10/9/2020

digital therapeutics that aid in the management of eight of the most common chronic conditions: diabetes, prediabetes, hypertension, asthma, pulmonary disease, depression, anxiety and insomnia. CVS Health’s Point Solutions Management helps employers to simplify contracting, secure the lowest price and monitor ongoing performance of 10 health apps, including digital programs to reduce stress, control high blood pressure, provide access to virtual physical therapy, lose weight and improve sleep habits, for …

Pear Therapeutics

Pear Therapeutics and PreferredOne Announce Broad Based Patient Access and Reimbursement for reSET® & reSET-O® for People with Substance Use Disorder and Opioid Use Disorder | Business Wire | 9/21/2020

Georgia Public Notices AP Pear Therapeutics and PreferredOne Announce Broad Based Patient Access and Reimbursement for reSET® & reSET-O® for People with Substance Use Disorder and Opioid Use Disorder Sep 21, 2020 2 hrs ago BOSTON & GOLDEN VALLEY, Minn.–(BUSINESS WIRE)–Sep 21, 2020– Pear Therapeutics, Inc. and PreferredOne announced today that reSET® and reSET-O®, the first two prescription digital therapeutics (PDTs) to receive authorization to treat disease from …

Noom

** | 9/21/2020**

Digital Therapeutics Market – What Factors will drive the Digital Therapeutics Market in Upcoming Years and How it is Going to Impact on Global Industry (2020-2027)Welldoc, Inc. Livongo Health Noom Inc. Ginger.Io, Inc. Propeller Health 2morrow Inc. Canary Health Inc. The Global Digital Therapeutics Market report is an investigative study of the market, along with an analysis of its key segments. The report is constructed through a thorough primary and …

Genentech

Pharma companies don’t want unicorn digital therapeutic partnerships | MobiHealthNews | 9/18/2020

Panelists at DTx East discuss the journey to implementing digital therapeutics into pharma and say more partnerships are likely. 01:01 pm Share Digital healths’ moment in the sun doesn’t appear to be ending anytime soon … Paul Upham, the head of smart devices at Roche and Genentech, said during the panel. Although pharmaceutical companies have a long way to go before they fully integrate digital therapeutics into their pipeline, if there’s …

Akili Interactive

Why digital therapeutics are flourishing under COVID-19 | MobiHealthNews | 9/17/2020

… this open moment because of COVID where everyone is aligned. Patients are desperate and want solutions. Providers see that these walls are broken down, and they want to respond,” Eddie Martucci, CEO of Akili Interactive, said this morning during a panel discussion. “Everyone understands that we have this taste of efficiency and rapid ability to serve the patient, and we’re seeing it happen in real time. I certainly hope that …

Johnson & Johnson

DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board | PR Newswire | 9/16/2020

NEW YORK , Sept. 16, DarioHealth Corp. (Nasdaq: DRIO ), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). Eric Milledge has worked in the healthcare field for his entire career, with a focus on pharmaceuticals and medical devices. With more than 34 years at Johnson & Johnson (JNJ) in roles of increasing responsibility, he …

VOLUNTIS

Voluntis Obtains €2 Million in Non-dilutive Financing | Business Wire | 9/14/2020

CAMBRIDGE, Mass. & PARIS- Regulatory News: Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, announces today that it has obtained a state-guaranteed loan (Prêt Garanti par l’Etat, or PGE in France) from BNP Paribas. This €2 million loan has an initial term of one year is fully repayable on maturity 1 . Repayment of the amounts due may be deferred again, at the company’s option, until September …

Boehringer Ingelheim

Boehringer’s schizophrenia med boosts cognition in phase 2 | FierceBiotech | 9/14/2020

Boehringer Ingelheim’s schizophrenia hopeful hit the mark in a phase 2 study, helping patients overcome cognitive impairment that can affect everyday tasks, such as remembering important dates or solving problems. The treatment, BI 425809, inhibits … oncology’s hottest fields. Save Your Spot RELATED: ATAI dives into digital therapeutics to boost mental health care In addition to hitting the study’s primary endpoint, the drug turned up no safety concerns, “with no differences …

Teladoc

Livongo and Magellan Health partner for digital mental health - Business Insider | 9/11/2020

Magellan Health is granting its customers access to Livongo's suite of behavioral health tools. And the forthcoming Livongo-Teladoc combined entity will be a force to be reckoned with when it comes to telemental health. publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can learn more about subscribing here. Managed healthcare company Magellan Health is making digital therapeutics

Click Therapeutics

Boehringer Ingelheim, Click Therapeutics ink $500M+ digital therapeutics development, commercialization deal | MobiHealthNews | 9/11/2020

The companies will be collaborating on a prescription digital therapeutic for patients with schizophrenia built on Click Therapeutics’ tech platform. 04:53 pm Share International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. The treatment, referred to as CT-155, will be a mobile app built on Click’s proprietary tech …

MediSafe

Medisafe Brings Precision and Speed to Patient Journeys with new Medisafe Maestro technology | PR Newswire | 9/10/2020

BOSTON , Sept. 10, 2020 /PRNewswire/ – Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform. This advanced technology seamlessly orchestrates medication adherence journeys with precision and speed, creating personalized patient support resources delivered through a digital drug companion. Medisafe supports the pharmaceutical ecosystem with digital patient support resources through its personalized digital drug companion and integrated Care Connector which activates real-time …

Proteus Digital Health

From big deals to bankruptcy, a digital health unicorn falls short. Here’s what other startups can learn from Proteus | FierceHealthcare | 9/4/2020

Hundreds of startups are trying to succeed in a digital health market that is now flush with cash. Investors poured $5.4 billion into healthcare technology startups in the first half of 2020, according to digital health venture capital firm Rock Health. But having a breakthrough technology is not enough to succeed. Case in point: Proteus Digital Health, a high-flying digital therapeutics startup that secured big pharmaceutical partnerships, raised close …

Novartis

Softbank leads $100M investment in remote monitoring startup Biofourmis - MedCity News | 9/3/2020

… patients fare after they are discharged from the hospital. Photo credit: Biofourmis Since it first struck a partnership with drugmaker Novartis in 2019, remote monitoring startup Biofourmis began developing systems to track how patients fare … but internationally as well.” Adding new therapeutics Biofourmis has several digital therapeutics in its pipeline, including ones that it has developed internally and brought in through acquisitions. Its current platform uses titration algorithms to provide …

Biofourmis

SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | MSN | 9/3/2020

Biofourmis , which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today it closed a $100 million Series C led by SoftBank Vision Fund 2, with participation from returning investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI …

Takeda Pharmaceuticals

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion | PR Newswire | 9/3/2020

BOSTON Biofourmis , a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2, [1] with … acquisitions during that time, including wearable biosensor leader Biovotion and Takeda Pharmaceuticals’ oncology-focused digital therapeutics company Gaido Health . “COVID-19 is pushing remote monitoring and digital therapeutics to the forefront of medicine,” said Biofourmis …

AstraZeneca

SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | MSN | 9/3/2020

… to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today … with seven pharmaceutical companies and 10 health systems, including Novartis, AstraZeneca, and Mayo Clinic. Biofourmis also made several acquisitions, including wearable biosensor startup Biovotion and Gaido Health, a digital therapeutics company for cancer patients. The …

CureApp

CureApp Named to the 2020 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups | PR Newswire | 8/24/2020

GDPR CureApp Named to the 2020 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups CureApp recognized for achievements in develop evidence-based medical programs, “Digital Therapeutics (DTx),” for patients who suffer from conditions that conventional treatment methods with drugs or devices were not effective News provided by Aug 24, 2020, 08:16 ET Share this article NEW YORK , Aug. 24, 2020 /PRNewswire/ – CB Insights today named CureApp

Goldman Sachs

UnitedHealth Group Inc. (UNH) Q3 2020 Earnings Call Transcript | 10/14/2020

… Wolfe Research — Analyst Frank Morgan — RBC Capital Markets — Analyst Ricky Goldwasser — Morgan Stanley — Analyst Gary Taylor — JPMorgan — Analyst Robert Jones — Goldman Sachs — Analyst Sarah James — Piper Sandler — Analyst David Windley — Jefferies — Analyst Presentation: Operator Good … people and producing better health outcomes. You can expect more digital therapeutics from us in the coming months and years. Our growing capacities are especially apparent within our OptumCare platform, where 53,000 physicians across 1,500 …

Rock Health

From big deals to bankruptcy, a digital health unicorn falls short. Here’s what other startups can learn from Proteus | FierceHealthcare | 9/4/2020

Hundreds of startups are trying to succeed in a digital health market that is now flush with cash. Investors poured $5.4 billion into healthcare technology startups in the first half of 2020, according to digital health venture capital firm Rock Health. But having a breakthrough technology is not enough to succeed. Case in point: Proteus Digital Health, a high-flying digital therapeutics startup that secured big pharmaceutical partnerships, raised close …

Sequoia Capital

SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | MSN | 9/3/2020

Biofourmis , which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today it closed a $100 million Series C led by SoftBank Vision Fund 2, with participation from returning investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI …

MassMutual Ventures

SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | MSN | 9/3/2020

Biofourmis , which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today it closed a $100 million Series C led by SoftBank Vision Fund 2, with participation from returning investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI …

EDBI

SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis | MSN | 9/3/2020

Biofourmis , which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today it closed a $100 million Series C led by SoftBank Vision Fund 2, with participation from returning investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI

Felicis Ventures

Startup Sprout launches tech-enabled autism care program with $10M seed financing | FierceHealthcare | 7/22/2020

… program, launched this week on the back of $10 million in seed funding. Institutional investors General Catalyst, Bling Capital and Felicis Ventures backed the round. Sprout CEO and co-founder Yury Yakubchyk said the company … are eyeing autism care as health’s next big bet. Pediatric digital therapeutics developer Cognoa is developing autism-focused therapeutic and diagnostic products , and the company has raised $20 million to date, according to Crunchbase. Opya …

Insight Partners

BrightInsight Raises $40 Million To Help Speed Up Digital Therapeutics Development | Forbes | 6/23/2020

… Series B round, and is one of the first companies to offer an integrated software platform for developing so-called digital therapeutics. “It’s the underlying secure, regulated infrastructure that enables our customer’s apps, devices, digital … and insulin pen. The current funding round was led by Insight Partners, with return investors including New Leaf Venture Partners and Eclipse Ventures. BrightInsight has raised $65 million to date. Life sciences companies face many …

Optum Ventures

Optum leads $26M funding round for digital therapeutics startup | Becker’s Hospital Review | 6/19/2020

Optum Ventures, the investment arm of UnitedHealth Group’s Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease, according to a June 18 news release emailed to Becker’s Hospital Review . The …

Innovation Fund

SilverCloud Health Announces $16M Series B Funding for Digital Mental Health Platform | Business Wire | 4/8/2020

… healthcare systems and providers, health plans, and employers, today announced a $16 million Series B funding round led by MemorialCare Innovation Fund , which included LRVHealth , OSF Ventures and UnityPoint Health Ventures , elevating the company’s total … digital mental health platform in Canada. This further demonstrates how digital therapeutics solutions are becoming a critical component of mental health treatment and support, and how SilverCloud is determined to stay the leader in delivering …

OpenView

The Funded: 6 Bay Area startups raise over $140M at end of week | The Business Journals | 3/20/2020

OpenView and Greenspring. • Mya Systems Inc., San Francisco, $18.75 million: Notion Capital led the Series C funding of this hiring chatbot. It was joined by Workday Ventures and return backers Foundation Capital and Emergence Capital. • Digital Therapeutics Inc. (dba Quit Genius), San Francisco, $11 million: Octopus Ventures led the Series A funding of this provider of digital therapeutics for addiction. It was joined by Y Combinator, Startup Health, Triple Point …

Accel

The Funded: 6 Bay Area startups raise over $140M at end of week | The Business Journals | 3/20/2020

… Accel, OpenView and Greenspring. • Mya Systems Inc., San Francisco, $18.75 million: Notion Capital led the Series C funding of this hiring chatbot. It was joined by Workday Ventures and return backers Foundation Capital and Emergence Capital. • Digital Therapeutics Inc. (dba Quit Genius), San Francisco, $11 million: Octopus Ventures led the Series A funding of this provider of digital therapeutics for addiction. It was joined by Y Combinator, Startup Health, Triple …

Lux Capital

No one knows how effective digital therapies are, but a new tool from Elektra Labs aims to change that | TechCrunch | 11/12/2019

… she took a coding bootcamp and returned to the world she was raised in by taking an internship with the digital therapeutics company Akili Interactive . Coravos always thought she wanted to be in healthcare, but … investors, including Maverick Ventures, Arkitekt Ventures, Boost VC, Founder Collective, Lux Capital, SV Angel and Village Global. Alongside several angel investors, including the founders and chief executives from companies including: PillPack, Flatiron Health, National Vision …

StartUp Health

Digital health investments bounced back in Q2 2019 with nearly $2.5B in funding | MobiHealthNews | 7/5/2019

… intelligence to take care of its members on a daily basis.” Series B $65 Redpoint Ventures, 8VC, Echo Health Ventures, StartUp Health, Sidewalk Labs, Thrive Capital, Maverick Ventures, Town Hall Ventures and EmbelmHealth The company … number of physical and behavioral chronic conditions. The offering includes digital therapeutics, digital communication with live health coaches and, in many cases, connected devices which send biometric data to coaches and apps. $30 Brookfield Growth …

HCSC Ventures

Solera Health Named Best Overall MedTech Company in 2019 by MedTech Breakthrough Awards Program | PR Newswire | 6/5/2019

… medical claims for achieving clinical outcomes. Most recently, Solera raised $42 million in health plan-driven capital infusion led by HCSC Ventures to expand the impact of its novel marketplace model to include social determinants … that connects patients, payers and physicians with community organizations and digital therapeutics providers, simply and securely. Solera helps consolidate highly fragmented programs and services into a single marketplace allowing health plans and medical providers to …

SGInnovate

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease | MedCity News | 5/22/2019

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease The company is moving its headquarters from Singapore to Boston alongside the capital raise. Post a comment / May 22, 2019 at 1:40 PM … 40 million from investors including Openspace Ventures, Aviva Ventures and SGInnovate. By the end of 2019, the company plans to have a workforce of more than 100 employees split across Boston and Singapore. “Sequoia India …

5AM Ventures

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

… Digital therapeutics: Novartis (NYSE: NVS ) was among the investors in a $50M Series B round for prescription digital therapeutics developer Pear Therapeutics. Temasek led the round with other new and returning investors 5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical …

Arboretum Ventures

Cancer diagnostics: Bristol-Myers (NYSE: BMY ) co-led a $75M | Seeking Alpha | 1/6/2018

… Digital therapeutics: Novartis (NYSE: NVS ) was among the investors in a $50M Series B round for prescription digital therapeutics developer Pear Therapeutics. Temasek led the round with other new and returning investors 5AM Ventures, Arboretum Ventures, the Bridge Builder’s Collaborative, JAZZ Venture Partners, and EDBI. The round brings total funding up to $70M. Pear Therapeutics received FDA approval last September for its reSET application, which was “the first mobile medical …

Mayo Clinic

On the agenda for INVEST Digital Health virtual Day 1: Hospital innovation and startups for chronic conditions, value-based care - MedCity News | 9/21/2020

… How Hospital Innovation is Changing Amidst a Pandemic . Arundhati will moderate and speakers will include: Rita Khan , Chief Digital Officer, Mayo Clinic and Genevieve Melton-Meaux, M.D. , Chief Analytics and Care Innovation Officer, M Health … CEO: Anuj Patel Headquarters: Cambridge, MA Limbix is building prescription digital therapeutics to treat adolescent mental health disorders. Its first product, Limbix Spark, is an app designed to treat adolescent depression, a leading cause of …

Cleveland Clinic

Where does the UAE stand in the digital transformation of healthcare? | MSN | 8/23/2020

… from that. But where does the UAE industry stand in terms of adopting digital technologies? Dr Rakesh Suri, CEO of Cleveland Clinic Abu Dhabi, believes the UAE is at the cutting edge of digital transformation … experience, making healthcare more sustainable. “In this context, we feel digital therapeutics is going to be an important segment and we are investing in it.” Digital therapeutics provides evidence-based care to chronic patients. “The …

Cleveland Clinic, Cleveland OH

Where does the UAE stand in the digital transformation of healthcare? | MSN | 8/23/2020

… from that. But where does the UAE industry stand in terms of adopting digital technologies? Dr Rakesh Suri, CEO of Cleveland Clinic Abu Dhabi, believes the UAE is at the cutting edge of digital transformation … experience, making healthcare more sustainable. “In this context, we feel digital therapeutics is going to be an important segment and we are investing in it.” Digital therapeutics provides evidence-based care to chronic patients. “The …

Cedars-Sinai Medical Center, Los Angeles CA

Innovative Medical Devices Help Healthcare Systems Become More Efficient | PR Newswire | 8/19/2020

Digital Therapeutics for the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles. “We have to use a health care strategy that deploys resources throughout an entire community, and that’s where remote monitoring comes in.” Nemaura Medical, Inc. (NASDAQ: NMRD ) announced breaking new today that it has, “issued a presentation outlining how CGM is being used by quarantined and hospitalised COVID-19 patients. The Company has previously reported …

Cedars-Sinai Medical Center

Innovative Medical Devices Help Healthcare Systems Become More Efficient | PR Newswire | 8/19/2020

Digital Therapeutics for the Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles. “We have to use a health care strategy that deploys resources throughout an entire community, and that’s where remote monitoring comes in.” Nemaura Medical, Inc. (NASDAQ: NMRD ) announced breaking new today that it has, “issued a presentation outlining how CGM is being used by quarantined and hospitalised COVID-19 patients. The Company has previously reported …

Harvard Medical School

Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual - MedCity News | 7/20/2020

… startups pitch in the first track of the INVEST Pitch Perfect competition. They include: Atentiv : Provider of proprietary clinically validated digital therapeutics that remediate the underlying cause of chronic behavioral disorders/ADHD – executive skills dysfunction … digital therapeutics company using proven, evidence-based singing therapies (from Harvard Medical School and McGill University, among others) to help hundreds of millions of people with neurological, hypertension, physical, pulmonary, and dementia challenges. CEO: Rachel …

Partners HealthCare

Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual - MedCity News | 7/20/2020

… Partners HealthCare, will open the conference. He will share how his nonprofit institution geared up to meet the challenge of Covid-19 and some of the major changes it implemented. Next, starting at 3:30 pm, we will have five health service startups pitch in the first track of the INVEST Pitch Perfect competition. They include: Atentiv : Provider of proprietary clinically validated digital therapeutics that remediate the underlying cause of chronic …

Kaiser Permanente

Big Health Raises $39 Million in Series B Financing from Gilde Healthcare, Morningside Ventures, Kaiser Permanente Ventures, and Octopus Ventures | PR Newswire | 6/18/2020

SAN FRANCISCO , June 18, Big Health , the global leader in digital therapeutics dedicated to helping millions back to good mental health, today announced it has raised $39 million in a Series B financing, led by Gilde Healthcare and joined by co-lead Morningside Ventures; existing investors Kaiser Permanente Ventures (KPV) and Octopus Ventures; and Samsung NEXT. Janke Dittmer , general partner at Gilde and Isaac Cheng, partner at Morningside, will join …

Children’s Hospital Los Angeles

The Innovation Studio at Children’s Hospital Los Angeles Announces Winners of Digital Health Lab Demo Day | Business Wire | 10/21/2019

… digital therapeutics, improving clinical education and reimagining the patient and provider experience. “It’s been a thrilling six months mentoring the teams and witnessing their unbridled enthusiasm as they worked to enhance the lives of pediatric patients, who remain an underserved population within the health-tech innovation space,” said Omkar Kulkarni, MPH, Chief Innovation Officer at Children’s Hospital Los Angeles. “We are eager to embark on the implementation phase, where we …

Children's Hospital Los Angeles, Los Angeles CA

The Innovation Studio at Children’s Hospital Los Angeles Announces Winners of Digital Health Lab Demo Day | Business Wire | 10/21/2019

LOS ANGELES- The Innovation Studio at Children’s Hospital Los Angeles (CHLA) announced the winners of its first ever Digital Health Lab Demo Day, the culmination of a six-month venture to develop, incubate and implement … teams, all of which share the common goal of enhancing digital therapeutics, improving clinical education and reimagining the patient and provider experience. “It’s been a thrilling six months mentoring the teams and witnessing their unbridled …

Beth Israel Deaconess Medical Center

Top 7 Evidence-Based Mental Health Apps | 10/16/2019

… recently-published interview with John Torous, MD, MBI, Director of the Digital Psychiatry Division at the Department of Psychiatry at Beth Israel Deaconess Medical Center, there are seven great evidenced-based mental health apps you … prescription only products that are approved by the FDA as digital therapeutics.” I couldn’t agree more. Just because an app appears in the App Store or on Google Play doesn’t mean it’s been vetted in …

Hartford HealthCare

Glytec Introduces Quality Team to Assist Healthcare Organizations With Achieving Clinical Excellence in Diabetes Care | Business & Finance | manchestertimes.com | Business Wire | 10/16/2019

… Betsy Kubacka, MSN, AGPCNP-BC, RDN, CDE, Director of Clinical Practice Betsy is a former inpatient diabetes clinical coordinator for Hartford HealthCare , where she co-chaired the health system’s Endocrine Council and provided leadership on … About Glytec Founded in 2006, Glytec is the pioneer of digital therapeutics, improving the lives of people with diabetes by making insulin a more effective and accessible option for millions unable to achieve their treatment …

Department of Veterans Affairs

Virta Health and Blue Shield of California are teaming up on diabetes treatment (ANTM) | Business Insider | 9/11/2019

… Intelligence Digital Health Pro subscribers. To receive the full story plus other insights each morning, click here. San Francisco-based digital therapeutics (DTx) company Virta Health announced it secured a coverage agreement with Blue Shield … for the DTx startup: Virta linked up with the US Department of Veterans Affairs (VA) for a 400-person pilot of the company’s dietary treatment program earlier this spring. Here’s what it means: Virta’s value …

Brigham and Women's Hospital

Biofourmis’ RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias | Seeking Alpha | 4/30/2019

Brigham and Women’s Hospital and has also secured partnerships with over 5 leading global pharmaceutical companies for its Digital Therapeutics platform. The team has trained a densely connected convolutional neural network using more than a million single-lead ECG recordings collected from patients with a history of cardiac arrhythmias using a variety of ambulatory ECG monitoring devices, one of which is the ePatch extended holter monitor from BioTelemetry Inc., which …

Humana

Dennis Matheis, President of Optima Health, a Multi-line Health Plan With More Than 850,000 Members and over 26,000 Providers, and Former President of Anthem Blue Cross and Blue Shield Central Region, Appointed to the Board of DarioHealth Corp | PR Newswire | 7/6/2020

NEW YORK , July 6, DarioHealth Corp. (Nasdaq: DRIO ), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board of Directors … Blue Cross and Blue Shield of Missouri , CIGNA Healthcare and Humana Health Plan, as well as Advocate Health Care in Chicago . Mr. Matheis serves on the Executive Committee of the Virginia Association of Health Plans …

UnitedHealthcare is planning to set up Medicare centers in Walgreens stores | Business Insider | 11/26/2019

digital therapeutics tool for diabetes in Asia THE DIGITAL BANKING ECOSYSTEM: These are the key players, biggest shifts, and trends driving short- and long-term growth in one of the world’s largest industries Humana saved $3.5 billion on Medicare Advantage members in 2018 by transitioning to value-based agreements …

Blue Shield of California

Digbi Health’s Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California | PR Newswire | 11/25/2019

Digbi Health’s Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California Access to Personalized, Proven, Digital Therapeutics for Obesity and Diabetes Redefines Precision Care and Disease Management News provided by Digbi Health Nov 25, 2019, 09:04 ET MOUNTAIN VIEW, Calif. , Nov. 25, 2019 /PRNewswire/ – Digbi Health’s clinically validated, personalized obesity, pre-diabetes and type 2 diabetes management program tailored to a person’s …

The Digital Therapeutics Explainer from Business Insider Intelligence - Business Insider | 10/17/2019

This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report. Business Insider Intelligence offers even more healthcare coverage with Digital Health Pro. Subscribe today to receive industry-changing … Pharma, Aurora Health Care, Bayer, Better Therapeutics, Big Health, Biofourmis, Blue Shield of California, Cambia Health Solutions, Cigna, Click Therapeutics, Cognoa, CVS Caremark, DarioHealth, Dexcom, Diabeto, Eli Lilly, ExpressScripts, Glooko, Happify Health, Health2Sync, Kaia Health …

Cigna

Express Script prepares to launch stand-alone digital health formulary in 2020 | MedCity News | 5/17/2019

… new stand-alone digital health formulary it intends to offer starting in 2020. The company is now a part of Cigna after its $54 billion acquisition last year. Building and maintaining a formulary of pharmaceuticals … can provide and create a pathway to cover prescription-only digital therapeutics that are coming to market. “Express Scripts has had such an outsize role in managing pharmaceutical benefits, their establishment of a digital health …

Express Scripts plans formulary for apps, medical devices | Healthcare Dive | 5/17/2019

… costs through bulk purchasing of digital health products and create a smoother way to cover increasing demand for prescription-only digital therapeutics. Dive Insight: The digital health landscape continues to expand in breadth and volume … and behavioral health issues. Express Scripts was snapped up by Cigna in a $67 billion deal finalized late last year amidst a flurry of anticompetitive concerns. Cigna has previously signaled interest in tackling the high …

Kuldeep Singh Rajput

A Growing Warchest: These 11 S’pore Startups Raised Funding Of Up To S$395M Despite COVID-19 | MSN | 10/6/2020

digital therapeutics solutions. There has been a significant surge in demand for virtual care in the face of the pandemic and the startup has seen a significant increase in demand for its platform during this period of time. CEO and founder Kuldeep Singh Rajput had said that the firm’s revenue in the first half of the year alone was 10 times more than the whole of 2019. Thunes © Provided by …

Corey McCann

Pear Therapeutics and PreferredOne Announce Broad Based Patient Access and Reimbursement for reSET® & reSET-O® for People with Substance Use Disorder and Opioid Use Disorder | Business Wire | 9/21/2020

… WIRE)–Sep 21, 2020– Pear Therapeutics, Inc. and PreferredOne announced today that reSET® and reSET-O®, the first two prescription digital therapeutics (PDTs) to receive authorization to treat disease from the U.S. Food and Drug … and reSET-O in Minnesota and across the nation,” said Corey McCann, M.D., Ph.D., President and CEO of Pear Therapeutics. “We won’t rest until everyone who is suffering from addiction has covered access to our …

Eddie Martucci

Why digital therapeutics are flourishing under COVID-19 | MobiHealthNews | 9/17/2020

… in-person care. “There’s this open moment because of COVID where everyone is aligned. Patients are desperate and want solutions. Providers see that these walls are broken down, and they want to respond,” Eddie Martucci, CEO of Akili Interactive, said this morning during a panel discussion. “Everyone understands that we have this taste of efficiency and rapid ability to serve the patient, and we’re seeing it happen in real time …

Pierre Leurent

Voluntis Obtains €2 Million in Non-dilutive Financing | Business Wire | 9/14/2020

CAMBRIDGE, Mass. & PARIS- Regulatory News: Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, announces today that it has obtained a state-guaranteed loan (Prêt Garanti par l’Etat, or PGE in France … glad to announce this new loan from BNP Paribas” said Pierre Leurent, CEO of Voluntis . “This non-dilutive cash injection further reinforces our financial situation and will contribute to our growth initiatives in the digital …

Omri Shor

Medisafe Brings Precision and Speed to Patient Journeys with new Medisafe Maestro technology | PR Newswire | 9/10/2020

BOSTON , Sept. 10, 2020 /PRNewswire/ – Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform. This advanced technology seamlessly orchestrates medication adherence journeys with precision and speed … patient resources, bolstering treatment adherence, and improving patient outcomes,” said Omri Shor , Chief Executive Officer, Medisafe. “Optimizing patient journeys requires hundreds or thousands of modifications that can impact a patient, creating challenges or roadblocks to …

Kuldeep Singh

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion | PR Newswire | 9/3/2020

BOSTON Biofourmis , a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2, [1] with … digital therapeutics to the forefront of medicine,” said Biofourmis CEO Kuldeep Singh Rajput. “Our vision is to use digital medicine to empower patients, clinicians and researchers everywhere by providing software-as-a-treatment for patients …

Anand Sanwal

CureApp Named to the 2020 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups | PR Newswire | 8/24/2020

… Digital Health 150 – List of Most Innovative Digital Health Startups CureApp recognized for achievements in develop evidence-based medical programs, “Digital Therapeutics (DTx),” for patients who suffer from conditions that conventional treatment methods with drugs … to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal . “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized …

Kohta Satake

CureApp Named to the 2020 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups | PR Newswire | 8/24/2020

… Digital Health 150 – List of Most Innovative Digital Health Startups CureApp recognized for achievements in develop evidence-based medical programs, “Digital Therapeutics (DTx),” for patients who suffer from conditions that conventional treatment methods with drugs … of this year’s class of the best in digital health.” Kohta Satake , M.D. President and CEO, CureApp,Inc It is an incredible honor to have CureApp selected as one of the “Digital Health 150 Companies …

Erez Raphael

DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference | PR Newswire | 8/13/2020

NEW YORK DarioHealth Corp. (Nasdaq: DRIO ), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and … an important role in the management of diabetes and hypertension.” Erez Raphael , Chief Executive Officer of Dario, stated, “We are excited about these positive results observed across hundreds of patients. We believe that this latest …

Ed Cox

Council Post: Sharpening The Value And Definitions Of Digital And RWD: An Exchange Between Two Industry Leaders | Forbes | 7/14/2020

… President of Data & Analytics, at Eversana . The following is a recent email exchange between Brigham Hyde and fellow FTC member Ed Cox, two health tech experts and coworkers on a quest to educate each other … invasion is coming, and we’re beginning to use phrases like digital therapeutics and real-world evidence as shorthand for that inevitable (and ominous) transition. I think for most people, these are not yet actual things …

Rebecca Robbins

STAT Plus: Can a prescription video game actually make money? Akili is about to find out | 6/22/2020

Health Tech Can a prescription video game actually make money? Akili is about to find out By Rebecca Robbins @rebeccadrobbins June 22, 2020 Reprints Akili’s video game, EndeavorRx, got the green light from the FDA … game fares commercially could shape the fortunes of the emerging digital therapeutics sector, which is looking to Akili to chart a path for how to persuade doctors to prescribe software-based therapies — and how to …

Brian Harris

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic - PRNewswire | PR Newswire | 6/15/2020

PORTLAND, Maine , June 15, MedRhythms, a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has … potential to address a significant unmet need in healthcare,” said Brian Harris , CEO and co-founder of MedRhythms. “There is currently no standard of care for chronic stroke survivors with walking deficits, yet these impairments …

Yuri Maricich

Digital therapeutics make strides during pandemic, but still face adoption hurdles - MedCity News | 4/23/2020

… Yuri Maricich, CMO of Pear Therapeutics , explained what that process looks like for his company. Pear is a well-established player in the digital therapeutics space, with three FDA-cleared products for addiction treatment and insomnia, all of which are prescribed by a physician. The company has seen tens of thousands of patients using its products and coming back to refill their prescriptions. For the latter to happen, the company …

Scott Kelly

CytoDyn Appoints Samir Patel, M.D., to its Board of Directors | Globe Newswire | 4/20/2020

… joined its Board of Directors (the “Board”). Dr. Patel is an active entrepreneur serving as co-founder and CEO of Digital Therapeutics, LLC, co-founder of SPEC Pharma, LLC, consultant for GE Global Research, and … drug for the benefit of patients and our shareholders.” Dr. Scott Kelly, Chairman of the Board, Chief Medical Officer and Head of Business Development, added, “We are very pleased Dr. Patel has joined our Board …

Megan Coder

Trade group calls for government coverage of digital therapeutics amid pandemic | STAT | 4/8/2020

Health Tech With the pandemic sidelining routine care, a trade group urges the government to pay for digital therapeutics By Erin Brodwin @erbrod and Rebecca Robbins @rebeccadrobbins April 8, 2020 Adobe A prominent trade group … on the public side don’t have the same options,” said Megan Coder, executive director of the Digital Therapeutics Alliance, the group calling for broader coverage of such tools. The alliance includes 35 companies, some of …

Laura Wood

Global Digital Therapeutics (2020 to 2024) - Drivers, Challenges and Trends - ResearchAndMarkets.com | Business Wire | 4/6/2020

DUBLIN- The “Digital Therapeutics: A New Age Medicine” report has been added to ResearchAndMarkets.com’s offering. The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from … about this report visit https://www.researchandmarkets.com/r/6bz01t Contacts ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call …

Kevin McRaith

Welldoc Announces Collaboration with Dexcom to Enhance the Value of BlueStar® with the Dexcom G6® CGM System | PR Newswire | 3/11/2020

… our expertise - in the utilization of technology and data science to drive user engagement and clinical outcomes,” said Welldoc CEO Kevin McRaith . “This partnership is a significant milestone for Dexcom, Welldoc, healthcare providers, and most … and effective.” About Welldoc ® Welldoc ® , a founding member of the Digital Therapeutics Alliance, is a pioneer in revolutionizing chronic disease management to help transform lives. BlueStar ® was the first FDA-cleared digital health solution that …

Olivier Jarry

Walmart Starts Distributing the DarioHealth Digital Diabetes Management System | PR Newswire | 12/3/2019

BENTONVILLE, Arkansas and NEW YORK , Dec. 3, Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO ) announced today the launch of the Dario-powered digital diabetes program on Walmart.com . Walmart is the largest retailer in … one of the best solutions for managing chronic conditions,” said Olivier Jarry , DarioHealth’s President and Chief Commercial Officer. About DarioHealth Corp. DarioHealth Corp. (NASDAQ: DRIO ) is a leading global digital health company serving its users …

Brenda Schmidt

Digbi Health’s Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California | PR Newswire | 11/25/2019

… Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California Access to Personalized, Proven, Digital Therapeutics for Obesity and Diabetes Redefines Precision Care and Disease Management News provided by … members to the program that best meets their needs,” said Brenda Schmidt , CEO, Solera Health . Blue Shield of California , an innovative health insurer with 4.3 million members, launched Wellvolution in June. The digital therapeutics platform …

Andrea Park

Novartis launches program with Biofourmis for AI monitoring of heart failure patients | Becker’s Hospital Review | 11/21/2019

Novartis launches program with Biofourmis for AI monitoring of heart failure patients Andrea Park - Print Email Novartis has selected artificial intelligence-powered digital therapeutics company Biofourmis for a commercial project leveraging predictive analytics for early intervention in patients with low ejection fraction. Throughout the three-month program, recently discharged heart failure patients will use a wearable biosensor and accompanying app to track symptoms, manage medications and communicate with care teams …

Kenji Yasukawa

Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics | PR Newswire | 11/21/2019

TOKYO and COLUMBIA, Md. , Nov. 20, Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., “Astellas” ) and Welldoc, Inc. (President, CEO: Kevin McRaith , “Welldoc”) today announced that the companies have entered into a … BlueStar ® in the U.S. market, and jointly develop and commercialize digital therapeutics in other therapeutic areas globally. (PRNewsfoto/WellDoc Inc) BlueStar ® is a digital health solution that is cleared by the U.S. Food and Drug …

Jeff Dachis

One Drop Announces Blood Glucose Predictive Capability for People Using Continuous Glucose Monitors | PR Newswire | 11/18/2019

NEW YORK One Drop, a leader in digital therapeutics solutions for diabetes and other chronic conditions, announced last week at the Diabetes Technology Meeting that it has developed a model to accurately predict blood glucose … before they even occur,” said One Drop Founder and CEO Jeff Dachis . “One Drop’s predictive model offers the most accurate blood glucose forecasts based on real-world data that have been published to date. It’s …

Wayne Mackey

Statespace and Pro Football Hall of Fame Offer Cognitive Performance Evaluations to Heroes of the Game | Markets Insider | Business Insider | 10/28/2019

… Combine assessment measures perception, fine motor skills and cognition to get a baseline of cognitive performance. Statespace Founder and CEO Wayne Mackey , Ph.D. said: “Partnering with the Pro Football Hall of Fame was an absolute … over 1M users. Additional programs such as Cognitive Analytics and Digital Therapeutics are currently in development. Statespace recently closed a $2.5M USD funding round led by FirstMark Capital. Other investors include Expa, Lux Capital, and …

Richard Francis

Novartis terminates Pear Therapeutics partnership – Business Insider | 10/18/2019

digital therapeutics (DTx) for substance abuse (reSET) and opioid dependence (reSET-O). Business Insider Intelligence The news follows major shakeups at Sandoz — and it raises questions about other products Pear was working on with the drug maker. Earlier this year, Sandoz’s former CEO Richard Francis stepped down, and Sandoz acknowledged a shift in company priorities as part of the impetus behind terminating the partnership. The two companies have publicly stated …

Zvi Ben-David

DarioHealth to Host Third Quarter 2019 Conference Call October 28, 2019 | PR Newswire | 10/17/2019

NEW YORK and CAESAREA, Israel , Oct. 17, Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO ) today announced it will release its third quarter 2019 results on Monday, October 28 , and host a conference call … Executive Officer, Olivier Jarry , President and Chief Commercial Officer, and Zvi Ben-David , Chief Financial Officer. The live call can be accessed by dialing 1-844-369-8770 or 1-862-298-0840 (international). Participants should ask for the DarioHealth Earnings …

New York, New York

Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health | HIT Consultant | 11/5/2020

digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD). Financial details of the acquisition were not disclosed. Start breathing smarter Founded in 2013, New York-based Cohero Health develops innovative digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization. With this transaction, Aptar Pharma acquires Cohero Health‚Äôs turnkey digital health platform and device assets including: ¬∑ BreatheSmart Connect …

Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health | 10/23/2020

RSS Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health The global report on Digital Therapeutics and Wellness market presents, through a comprehensive analysis, the newly published research study that provides key industry insights and a competitive advantage for multiple stakeholders. New York, NY – ( SBWIRE ) – 10/23/2020 – Digital Therapeutics and Wellness report shows existing business research, future as well as emerging …

State of New York

Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health | HIT Consultant | 11/5/2020

digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD). Financial details of the acquisition were not disclosed. Start breathing smarter Founded in 2013, New York-based Cohero Health develops innovative digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization. With this transaction, Aptar Pharma acquires Cohero Health‚Äôs turnkey digital health platform and device assets including: ¬∑ BreatheSmart Connect …

Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health | 10/23/2020

RSS Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health The global report on Digital Therapeutics and Wellness market presents, through a comprehensive analysis, the newly published research study that provides key industry insights and a competitive advantage for multiple stakeholders. New York, NY – ( SBWIRE ) – 10/23/2020 – Digital Therapeutics and Wellness report shows existing business research, future as well as emerging …

York, Pennsylvania

Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health | HIT Consultant | 11/5/2020

digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD). Financial details of the acquisition were not disclosed. Start breathing smarter Founded in 2013, New York-based Cohero Health develops innovative digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization. With this transaction, Aptar Pharma acquires Cohero Health‚Äôs turnkey digital health platform and device assets including: ¬∑ BreatheSmart Connect …

Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health | 10/23/2020

RSS Digital Therapeutics and Wellness Market Upcoming Growth by Top Key Players: Proteus Digital Health, Omada Health, Welldoc, Livongo Health The global report on Digital Therapeutics and Wellness market presents, through a comprehensive analysis, the newly published research study that provides key industry insights and a competitive advantage for multiple stakeholders. New York, NY – ( SBWIRE ) – 10/23/2020 – Digital Therapeutics and Wellness report shows existing business research, future as well as emerging …

State of California

UnitedHealth Group Inc. (UNH) Q3 2020 Earnings Call Transcript | 10/14/2020

… enabling more rapid testing at considerable scale, while keeping the health workforce safe. We are supporting state testing operations in California, New Jersey, North Carolina, and Indiana and contact tracing in New York City. We … people and producing better health outcomes. You can expect more digital therapeutics from us in the coming months and years. Our growing capacities are especially apparent within our OptumCare platform, where 53,000 physicians across 1,500 …

Limbix digital therapeutic for adolescent mental health finds niche amid Covid-19 pandemic | 10/12/2020

One of the most important applications of digital therapeutics is in mental health, and with millions of Americans stuck at home due to the Covid-19 pandemic, that potential use has come to the fore more than ever. One company developing digital therapeutics for mental health is Palo Alto, California-based Limbix, which was the winner of the Pitch Perfect contest in the category of chronic disease management and value …

Portland, Oregon

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic - PRNewswire | PR Newswire | 6/15/2020

PORTLAND, Maine , June 15, MedRhythms, a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has received Breakthrough Device designation from the (FDA) for its patented digital therapeutic to treat chronic stroke walking deficits. This product is the first in the Company’s pipeline of digital therapeutics for neurologic disease and injury …

Portland startup gets expedited federal review for stroke recovery product | 6/15/2020

A program developed by MedRhythms uses sensors, music and software to help stroke survivors overcome walking impairment. 207-791-6325 Share Federal regulators have granted a special designation to a Portland company’s digital therapeutics program that is under development to fast-track the product’s rollout. MedRhythms is building a direct simulation that uses sensors, music and software to lessen walking impairments brought on by stroke . The company on Monday had its program …

Charlotte, North Carolina

Orexo Presents the Interim Report for Q1 2020 | PR Newswire | 4/28/2020

… net revenues of SEK 11.1 m (12.6). US Pharma (Zubsolv US) EBIT of SEK 75.9 m (68.2), up 11.2 percent, Digital Therapeutics EBIT of SEK -12.0 m (-) and HQ & Pipeline EBIT of SEK -29.9 m … the company James Noble elected Chairman of the Board and Charlotte Hansson elected as Board member at the Annual General Meeting. They replace Martin Nicklasson and Kristina Schauman who have declined re-election. Financial outlook …

Orexo Presents the Interim Report for Q1 2020 | Yahoo News | 4/28/2020

… net revenues of SEK 11.1 m (12.6). US Pharma (Zubsolv US) EBIT of SEK 75.9 m (68.2), up 11.2 percent, Digital Therapeutics EBIT of SEK -12.0 m (-) and HQ & Pipeline EBIT of SEK -29.9 m … the company James Noble elected Chairman of the Board and Charlotte Hansson elected as Board member at the Annual General Meeting. They replace Martin Nicklasson and Kristina Schauman who have declined re-election. Financial outlook …

State of Maine

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic - PRNewswire | PR Newswire | 6/15/2020

PORTLAND, Maine , June 15, MedRhythms, a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has received Breakthrough Device designation from the (FDA) for its patented digital therapeutic to treat chronic stroke walking deficits. This product is the first in the Company’s pipeline of digital therapeutics for neurologic disease and injury …

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic | 6/15/2020

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic Published: Jun 15, 2020 PORTLAND, Maine , June 15, 2020 /PRNewswire/ – MedRhythms , a Portland, Maine -based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its patented digital therapeutic to …